Semiquantitative analysis of the results by TotaLab TL120 (Shimadzu Co., Ltd., Kyoto) revealed that the difference in serum clusterin levels between HCC and LC was statistically significant (468211.38 ± 103972.69 versus 341686.90 ± 123162.85, P = 0.023) as indicated in Figure 6(b). The gene discussed is CLU; the disease is laryngotracheoesophageal cleft.